RGEN241220C190000
- 0.65
- 0.000.00%
Repligen Newsroom
Repligen(RGEN.US) Director Sells US$3.39 Million in Common Stock
Express News | Form 144 | Repligen(RGEN.US) Insider Proposes to Sell 3.39 Million in Common Stocks
Repligen | 10-Q: Q3 2024 Earnings Report
Repligen | 10-K/A: Annual report (Amendment)
Repligen | 10-Q/A: Quarterly report (Amendment)
Repligen Analyst Ratings
Wolfe Research Initiates Repligen(RGEN.US) With Hold Rating
Repligen Initiated With a Peer Perform at Wolfe Research
Express News | Repligen Corp : UBS Raises Target Price to $190 From $185
Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
Benchmark Co. Maintains Repligen(RGEN.US) With Hold Rating
Repligen (RGEN) Receives a Hold From Benchmark Co.
RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $205
Repligen's Strong Q3 and Strategic Moves
KeyBanc Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $220
Top Gap Ups and Downs on Tuesday: HON, SHOP, SE and More
Repligen to File Q3 10-Q Report Late
Repligen Corporation (RGEN) Q3 2024 Earnings Call Transcript Summary
10 Health Care Stocks Whale Activity In Today's Session
Top Midday Gainers